Frank McCormick

Director, BridgeBio Pharma, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$13.2M

Companies

Latest trade

Oct 29, 2025

Companies

BridgeBio Pharma, Inc.Director −$13.3M

Trades

BBIO Sold 198,359 shares at $66.58 · planned $13.2M Oct 29

BBIO Sold 1,641 shares at $65.00 · planned $0.1M Oct 27

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.